OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AAME$2.2752

Atlantic American Corp

Life & Health InsuranceVerified

Atlantic American Corp has a market price of $2.27, with a market capitalization of $46.3 million, and a price-to-book ratio of 0.46, indicating that the company is trading at a significant discount to its book value. The company's liquidity position is characterized as medium, with $35.6 million in cash and equivalents, but its free cash flow is negative at -$5.3 million, suggesting that the company is not generating sufficient cash from operations to cover capital expenditures. The debt-to-equity ratio of 0.38 indicates a relatively conservative capital structure, with long-term debt of $37.8 million compared to total equity of $99.6 million. The company's profitability is underperforming, with a return on equity of -4.28% and a return on assets of -1.08%, both of which are negative and significantly below the industry median for life and health insurers. The operating loss of $1.85 million and net loss of $4.27 million further underscore the company's current financial challenges. These figures suggest that the company is not only failing to generate returns for shareholders but is also experiencing declining operational efficiency. Atlantic American Corp's revenue is concentrated within the life and health insurance segment, with no disclosed geographic diversification in the provided data. This lack of diversification may expose the company to higher risk in the event of a downturn in the insurance market or regulatory changes affecting the sector. The company's exposure to a single business line without geographic diversification could limit its ability to adapt to market shifts or capitalize on growth opportunities in other regions. The company's growth trajectory is negative, with a net loss of $4.27 million in the latest reporting period. The outlook for the current fiscal year is not explicitly provided, but the negative operating and net income figures suggest a challenging environment. The company's capital expenditures of -$225,000 indicate a reduction in investment, which may be a response to the current financial constraints. The lack of positive growth indicators and the company's current financial performance suggest that the company is not in a position to expand or invest in new opportunities in the near term. The risk assessment for Atlantic American Corp highlights a medium liquidity risk, with a negative net cash position after subtracting total debt. The company's dilution risk is classified as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's negative net income and operating cash flow may limit its ability to raise additional capital without diluting existing shareholders. The risk assessment does not identify any specific regulatory or geopolitical risks, but the company's exposure to the insurance sector may be affected by changes in regulatory requirements or market conditions. Recent events and filings for Atlantic American Corp do not provide specific details on recent developments, but the company's financial performance suggests a challenging operating environment. The company's negative operating and net income figures may be indicative of broader industry challenges or internal operational inefficiencies. The lack of positive financial performance and the company's current liquidity position may require the company to take corrective actions to stabilize its financial position.

30-day price · AAME+0.06 (+2.7%)
Low$2.13High$2.73Close$2.25As of16 May, 00:00 UTC
Profile
CompanyAtlantic American Corp
TickerAAME.O
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Atlantic American Corp has a market price of $2.27, with a market capitalization of $46.3 million, and a price-to-book ratio of 0.46, indicating that the company is trading at a significant discount to its book value. The company's liquidity position is characterized as medium, with $35.6 million in cash and equivalents, but its free cash flow is negative at -$5.3 million, suggesting that the company is not generating sufficient cash from operations to cover capital expenditures. The debt-to-equity ratio of 0.38 indicates a relatively conservative capital structure, with long-term debt of $37.8 million compared to total equity of $99.6 million. The company's profitability is underperforming, with a return on equity of -4.28% and a return on assets of -1.08%, both of which are negative and significantly below the industry median for life and health insurers. The operating loss of $1.85 million and net loss of $4.27 million further underscore the company's current financial challenges. These figures suggest that the company is not only failing to generate returns for shareholders but is also experiencing declining operational efficiency. Atlantic American Corp's revenue is concentrated within the life and health insurance segment, with no disclosed geographic diversification in the provided data. This lack of diversification may expose the company to higher risk in the event of a downturn in the insurance market or regulatory changes affecting the sector. The company's exposure to a single business line without geographic diversification could limit its ability to adapt to market shifts or capitalize on growth opportunities in other regions. The company's growth trajectory is negative, with a net loss of $4.27 million in the latest reporting period. The outlook for the current fiscal year is not explicitly provided, but the negative operating and net income figures suggest a challenging environment. The company's capital expenditures of -$225,000 indicate a reduction in investment, which may be a response to the current financial constraints. The lack of positive growth indicators and the company's current financial performance suggest that the company is not in a position to expand or invest in new opportunities in the near term. The risk assessment for Atlantic American Corp highlights a medium liquidity risk, with a negative net cash position after subtracting total debt. The company's dilution risk is classified as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's negative net income and operating cash flow may limit its ability to raise additional capital without diluting existing shareholders. The risk assessment does not identify any specific regulatory or geopolitical risks, but the company's exposure to the insurance sector may be affected by changes in regulatory requirements or market conditions. Recent events and filings for Atlantic American Corp do not provide specific details on recent developments, but the company's financial performance suggests a challenging operating environment. The company's negative operating and net income figures may be indicative of broader industry challenges or internal operational inefficiencies. The lack of positive financial performance and the company's current liquidity position may require the company to take corrective actions to stabilize its financial position.
Key takeaways
  • Atlantic American Corp is trading at a significant discount to its book value, with a price-to-book ratio of 0.46.
  • The company is experiencing negative returns on equity and assets, indicating poor profitability.
  • The company's liquidity position is medium, with a negative free cash flow and a net cash position that is negative after subtracting total debt.
  • The company's growth trajectory is negative, with a net loss in the latest reporting period.
  • The company's risk assessment highlights a medium liquidity risk and a low dilution risk.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income-$1.8M
Net income-$4.3M
R&D
SG&A
D&A
SBC
Operating cash flow$4.8M
CapEx-$225.0k
Free cash flow-$5.3M
Total assets$393.4M
Total liabilities$293.8M
Total equity$99.6M
Cash & equivalents$35.6M
Long-term debt$37.8M
Valuation
Market price$2.27
Market cap$46.3M
Enterprise value$48.5M
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF10.1
P/B0.5
P/Tangible book0.5
Tangible book$99.6M
Net cash-$2.2M
Current ratio
Debt/Equity0.4
ROA-1.1%
ROE-4.3%
Cash conversion-1.1%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricAAMEActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity38.0%27.5% medp25 4.7% · p75 66.5%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 16:49 UTC#37cdce15
Market quoteclose USD 2.37 · shares 0.02B diluted
no public URL
2026-05-16 16:51 UTC#576c4dc4
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 05:50 UTCJob: 9d461177